Pyrimidine derivatives and oligonucleotides containing same

Details Pyrimidine derivatives and oligonucleotides containing same Pyrimidine derivatives and oligonucleotides containing same

2006-10-03

2006-10-03

Lewis, Patrick (Department: 1623)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S023100, C536S025300, C536S025310, C536S025320, C536S025340, C536S025400, C544S249000

Reissue Patent

active

RE039324

ABSTRACT:
Compounds having structure (1)wherein R1is —H a protecting group, a linker or a binding partner; and R2and R34are as defined in the specification. The invention also provides intermediates and methods make the structure (1) compounds, as well as methods to use the compounds as labels in diagnostic assays and to enhance binding to complementary bases.

REFERENCES:
patent: 4233402 (1980-11-01), Maggio et al.
patent: 5286717 (1994-02-01), Cohen et al.
patent: 5502177 (1996-03-01), Matteucci et al.
patent: 5594121 (1997-01-01), Froehler et al.
patent: 5614617 (1997-03-01), Cook et al.
patent: 5614622 (1997-03-01), Iyer et al.
patent: 5623068 (1997-04-01), Reddy et al.
patent: 5645985 (1997-07-01), Froehler et al.
patent: 5668272 (1997-09-01), Prasad et al.
patent: 5728528 (1998-03-01), Mathies et al.
patent: 0 487 289 (1992-05-01), None
patent: 0 541 153 (1993-05-01), None
patent: 62-059293 (1987-03-01), None
patent: WO 88/10264 (1988-12-01), None
patent: WO 90/15065 (1990-12-01), None
patent: WO 91/06626 (1991-05-01), None
patent: WO 91/06629 (1991-05-01), None
patent: WO 92/02258 (1992-02-01), None
patent: WO 92/20702 (1992-11-01), None
patent: WO 93/10820 (1993-06-01), None
patent: WO 93/13121 (1993-07-01), None
patent: WO 93/24507 (1993-12-01), None
patent: WO 96/05298 (1996-02-01), None
patent: WO 96/37504 (1996-11-01), None
patent: WO 97/14706 (1997-04-01), None
patent: WO 97/28176 (1997-08-01), None
patent: WO 97/31008 (1997-08-01), None
patent: WO 97/32888 (1997-09-01), None
Bell, et al., “Highly Effective Hydrogen-Bonding Receptors for Guanine Derivatives”, 34(19):2163-2165, Angew Chem Int Ed, 1995.
Dande, et al., “Regioselective Effect of Zwitterionic DNA Substitutions on DNA Alkylation: Evidence for a Strong Side Chain Orientational Preference”, 36:6024-6032, Biochem, 1997.
Haginoya et al., “Nucleosides and Nucleotides. 160, Synthesis of Oligodeoxyribonucleotides Containing 5-(N-Aminoalkyl)carbamoyl-2′-deoxyuridines by a New Postsynthetic Modification Method and Their Thermal Stability and Nuclease-Resistance Properties”, 8:271-280, Bioconj Chem, 1997.
Lin et al., “Tricyclic 2′-Deoxycytidine Analogs: Synthesis and Incorporation into Oligodeoxynucleotides Which Have Enhanced Binding to Complementary RNA”, 117:3873-3874, J. Am Chem Soc, 1995.
Matteucci et al., “In pursuit of antisense”, 384(7):20-22, Nature, 1996.
Prober et al., “A System for Rapid DNA Sequencing with Fluorescent Chain-Terminating Dideoxynucleotides”, 238:336-341, Science, 1987.
Ueno et al., “Effects of 5-(N-aminohexyl)carbamoyl-2′-deoxyuridine on endonuclease stability and the ability of oligodeoxynucleotide to activate RNase H”, 25(19):3777-3782, Nuc Acids Res, 1997.
Uhlmann et al, “Antisense Oligonucleotides: A New Therapeutic Principle”, 90(4):543-584, Chem Rev, 1990.

Affiliated with

Also associated with

Rating

Pyrimidine derivatives and oligonucleotides containing same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidine derivatives and oligonucleotides containing same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives and oligonucleotides containing same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3692575